Literature DB >> 31127475

Back-to-back random-start ovarian stimulation prior to chemotherapy to maximize oocyte yield.

Kaitlyn Wald1, Hakan Cakmak2, Evelyn Mok-Lin2, Marcelle Cedars2, Mitchell Rosen2, Joseph Letourneau2,3.   

Abstract

PURPOSE: To evaluate the feasibility of utilizing back-to-back random-start ovarian stimulation to increase oocyte yield for fertility preservation prior to cancer treatment.
METHODS: A case series of 15 patients who underwent back-to-back random-start stimulation cycles prior to chemotherapy.
RESULTS: Of the 15 back-to-back random-start stimulation cases, 13 had breast cancer and 2 had other cancers. The average age was 38 years (range 30-43) and average AFC was 8 (range 3-14). Fourteen of the 15 women (93%) who underwent two ovarian stimulation cycles completed both of them. The average time to complete back-to-back random-start ovarian stimulation was 33 days (range 13-43 days). The average time between the first cycle completion and the second cycle start in our back-to-back random-start stimulations was 9 days (range 0-14 days). Two of the women underwent back-to-back random-start ovarian stimulation prior to starting neoadjuvant chemotherapy for breast cancer. Eleven of our 15 women at least doubled their oocyte or embryo yield relative to their first cycle. Only 1 of the 15 second cycles was canceled. The mature oocyte rate, fertilization rate, and embryo yield were similar among the first and second cycles.
CONCLUSIONS: Back-to-back random-start ovarian stimulation may be an effective way to maximize fertility preservation, even in time-limited settings.

Entities:  

Keywords:  Cancer; Diminished ovarian reserve; Fertility preservation; Ovarian stimulation

Mesh:

Year:  2019        PMID: 31127475      PMCID: PMC6603104          DOI: 10.1007/s10815-019-01462-5

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  21 in total

1.  Pretreatment fertility counseling and fertility preservation improve quality of life in reproductive age women with cancer.

Authors:  Joseph M Letourneau; Erin E Ebbel; Patricia P Katz; Audra Katz; Wei Z Ai; A Jo Chien; Michelle E Melisko; Marcelle I Cedars; Mitchell P Rosen
Journal:  Cancer       Date:  2011-09-01       Impact factor: 6.860

2.  Safety and feasibility of performing two consecutive ovarian stimulation cycles with the use of letrozole-gonadotropin protocol for fertility preservation in breast cancer patients.

Authors:  Volkan Turan; Giuliano Bedoschi; Fred Moy; Kutluk Oktay
Journal:  Fertil Steril       Date:  2013-09-19       Impact factor: 7.329

Review 3.  Folliculogenesis in the primate ovarian cycle.

Authors:  G S diZerega; G D Hodgen
Journal:  Endocr Rev       Date:  1981       Impact factor: 19.871

4.  Successful Oocyte Cryopreservation in Reproductive-Aged Cancer Survivors.

Authors:  Sarah Druckenmiller; Kara N Goldman; Patty A Labella; M Elizabeth Fino; Antonia Bazzocchi; Nicole Noyes
Journal:  Obstet Gynecol       Date:  2016-03       Impact factor: 7.661

5.  Double stimulations during the follicular and luteal phases of poor responders in IVF/ICSI programmes (Shanghai protocol).

Authors:  Yanping Kuang; Qiuju Chen; Qingqing Hong; Qifeng Lyu; Ai Ai; Yonglun Fu; Zeev Shoham
Journal:  Reprod Biomed Online       Date:  2014-09-06       Impact factor: 3.828

6.  Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation.

Authors:  Kutluk Oktay; Erkan Buyuk; Natalie Libertella; Munire Akar; Zev Rosenwaks
Journal:  J Clin Oncol       Date:  2005-04-11       Impact factor: 44.544

7.  Neoadjuvant Chemotherapy for Breast Cancer, Is Practice Changing? A Population-Based Review of Current Surgical Trends.

Authors:  Peter J Graham; Mantaj S Brar; Tianne Foster; Mike McCall; Antoine Bouchard-Fortier; Walley Temple; May Lynn Quan
Journal:  Ann Surg Oncol       Date:  2015-07-23       Impact factor: 5.344

Review 8.  Assessing ovarian response: antral follicle count versus anti-Müllerian hormone.

Authors:  Richard Fleming; David B Seifer; John L Frattarelli; Jane Ruman
Journal:  Reprod Biomed Online       Date:  2015-07-03       Impact factor: 3.828

Review 9.  Infertility in reproductive-age female cancer survivors.

Authors:  Jennifer M Levine; Joanne Frankel Kelvin; Gwendolyn P Quinn; Clarisa R Gracia
Journal:  Cancer       Date:  2015-02-03       Impact factor: 6.860

10.  Effective method for emergency fertility preservation: random-start controlled ovarian stimulation.

Authors:  Hakan Cakmak; Audra Katz; Marcelle I Cedars; Mitchell P Rosen
Journal:  Fertil Steril       Date:  2013-08-26       Impact factor: 7.329

View more
  4 in total

Review 1.  Fertility preservation in breast cancer with case-based examples for guidance.

Authors:  Mary E Hampe; Alice S Rhoton-Vlasak
Journal:  J Assist Reprod Genet       Date:  2020-02-01       Impact factor: 3.412

2.  Double Ovarian Stimulation in the Same Ovarian Cycle.

Authors:  Corina Gica; Bogdan-Gabriel Maxim; Radu Botezatu; Gheorghe Peltecu; Anca Maria Panaitescu; Diana Iordachescu; Nicolae Gica
Journal:  Maedica (Bucur)       Date:  2021-03

3.  Fertility preservation in an oncology patient who presented with positive human chorionic gonadotropin.

Authors:  Olivia Carpinello; Alexandra Aserlind; Frank Chang; Arthur Sagoskin; Eric Widra
Journal:  F S Rep       Date:  2020-06-30

Review 4.  Gender-specific aspects related to type of fertility preservation strategies and access to fertility care.

Authors:  Marta Perachino; Claudia Massarotti; Maria Grazia Razeti; Francesca Parisi; Luca Arecco; Alessandra Damassi; Piero Fregatti; Cinzia Solinas; Matteo Lambertini
Journal:  ESMO Open       Date:  2020-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.